These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

734 related articles for article (PubMed ID: 16511588)

  • 41. Basic guide to the mechanisms of antiestrogen action.
    MacGregor JI; Jordan VC
    Pharmacol Rev; 1998 Jun; 50(2):151-96. PubMed ID: 9647865
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical function of estrogen receptors in endometrial cancer].
    Caringella AM; Di Naro E; Loverro G
    Minerva Ginecol; 2011 Dec; 63(6):495-504. PubMed ID: 22036754
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ERR receptors as potential targets in osteoporosis.
    Gallet M; Vanacker JM
    Trends Endocrinol Metab; 2010 Oct; 21(10):637-41. PubMed ID: 20674386
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dissection of the molecular mechanism of action of GW5638, a novel estrogen receptor ligand, provides insights into the role of estrogen receptor in bone.
    Willson TM; Norris JD; Wagner BL; Asplin I; Baer P; Brown HR; Jones SA; Henke B; Sauls H; Wolfe S; Morris DC; McDonnell DP
    Endocrinology; 1997 Sep; 138(9):3901-11. PubMed ID: 9275080
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human breast cancer progression can be regulated by dominant trans-acting factors in somatic cell hybridization studies.
    Safarians S; Sternlicht MD; Yamanishi DT; Love SM; Barsky SH
    Cancer Res; 1996 Aug; 56(15):3560-9. PubMed ID: 8758927
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Seven sirtuins for seven deadly diseases of aging.
    Morris BJ
    Free Radic Biol Med; 2013 Mar; 56():133-71. PubMed ID: 23104101
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hormonal mechanisms underlying the relationship between obesity and breast cancer.
    Perks CM; Holly JM
    Endocrinol Metab Clin North Am; 2011 Sep; 40(3):485-507, vii. PubMed ID: 21889716
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of the Nrf2 antioxidant pathway by microRNAs: New players in micromanaging redox homeostasis.
    Cheng X; Ku CH; Siow RC
    Free Radic Biol Med; 2013 Sep; 64():4-11. PubMed ID: 23880293
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human Disease Modelling Techniques: Current Progress.
    Glanz VY; Orekhov AN; Deykin AV
    Curr Mol Med; 2018; 18(10):655-660. PubMed ID: 30727892
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of sex steroid receptors in obstetrics and gynecology.
    Roberts DK; Van Sickle M; Kelly RW
    Obstet Gynecol Annu; 1983; 12():61-78. PubMed ID: 6866353
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estrogen receptor polymorphisms: significance to human physiology, disease and therapy.
    Figtree GA; Noonan JE; Bhindi R; Collins P
    Recent Pat DNA Gene Seq; 2009; 3(3):164-71. PubMed ID: 19673701
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ER-alpha variants and the cardiovascular effects of hormone replacement therapy.
    Herrington DM; Howard TD
    Pharmacogenomics; 2003 May; 4(3):269-77. PubMed ID: 12718718
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Different modulation of ER-mediated transactivation by xenobiotic nuclear receptors depending on the estrogen response elements and estrogen target cell types.
    Min G
    Ann N Y Acad Sci; 2006 Dec; 1091():244-57. PubMed ID: 17341619
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Membrane estrogen receptors - is it an alternative way of estrogen action?
    Soltysik K; Czekaj P
    J Physiol Pharmacol; 2013 Apr; 64(2):129-42. PubMed ID: 23756388
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of estrogens on neurodegenerative processes.
    Członkowska A; Ciesielska A; Joniec I
    Med Sci Monit; 2003 Oct; 9(10):RA247-56. PubMed ID: 14523340
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recent genetic discoveries in osteoporosis, sarcopenia and obesity.
    Urano T; Inoue S
    Endocr J; 2015; 62(6):475-84. PubMed ID: 25866211
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].
    Rochefort H
    C R Seances Soc Biol Fil; 1998; 192(2):241-51. PubMed ID: 9841098
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hormone-nuclear receptor interactions in health and disease. The oestrogen receptor.
    Auchus RJ; Fuqua SA
    Baillieres Clin Endocrinol Metab; 1994 Apr; 8(2):433-49. PubMed ID: 7522434
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clues to understanding the role of estrogen receptors in mediating cardiovascular protection.
    Du XJ
    Cardiovasc Res; 2002 Oct; 56(1):4-7. PubMed ID: 12237160
    [No Abstract]   [Full Text] [Related]  

  • 60. Analysis of the molecular pharmacology of estrogen receptor agonists and antagonists provides insights into the mechanism of action of estrogen in bone.
    McDonnell DP; Norris JD
    Osteoporos Int; 1997; 7 Suppl 1():S29-34. PubMed ID: 9205643
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.